Work

223 (PB211): PHI-101 synergizes with chemotherapy and PARP inhibitors in preclinical models of ovarian cancer

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114741

Authors: G.J. Sung, H.S. Hwang, J. Kwon, K.Y. Nam, J.H. Han, J.H. Yoon, K.T. Kim

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403763299

FWCI:

Cites:

Cited by:

Related to: 10